BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 23464740)

  • 1. Decrease of autophagy activity promotes malignant progression of tongue squamous cell carcinoma.
    Wang Y; Wang C; Tang H; Wang M; Weng J; Liu X; Zhang R; Huang H; Hou J
    J Oral Pathol Med; 2013 Aug; 42(7):557-64. PubMed ID: 23464740
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beclin1 inhibits proliferation, migration and invasion in tongue squamous cell carcinoma cell lines.
    Weng J; Wang C; Wang Y; Tang H; Liang J; Liu X; Huang H; Hou J
    Oral Oncol; 2014 Oct; 50(10):983-90. PubMed ID: 25096824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer-associated fibroblasts confer cisplatin resistance of tongue cancer via autophagy activation.
    Liao JK; Zhou B; Zhuang XM; Zhuang PL; Zhang DM; Chen WL
    Biomed Pharmacother; 2018 Jan; 97():1341-1348. PubMed ID: 29156523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lower mRNA and protein expression levels of LC3 and Beclin1, markers of autophagy, were correlated with progression of renal clear cell carcinoma.
    Deng Q; Wang Z; Wang L; Zhang L; Xiang X; Wang Z; Chong T
    Jpn J Clin Oncol; 2013 Dec; 43(12):1261-8. PubMed ID: 24186908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Receptor for advanced glycation end product blockade enhances the chemotherapeutic effect of cisplatin in tongue squamous cell carcinoma by reducing autophagy and modulating the Wnt pathway.
    Zhao Z; Wang H; Zhang L; Mei X; Hu J; Huang K
    Anticancer Drugs; 2017 Feb; 28(2):187-196. PubMed ID: 27831944
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nifedipine induced autophagy through Beclin1 and mTOR pathway in endometrial carcinoma cells.
    Bao XX; Xie BS; Li Q; Li XP; Wei LH; Wang JL
    Chin Med J (Engl); 2012 Sep; 125(17):3120-6. PubMed ID: 22932192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Upregulation of the long non-coding RNA AFAP1-AS1 affects the proliferation, invasion and survival of tongue squamous cell carcinoma via the Wnt/β-catenin signaling pathway.
    Wang ZY; Hu M; Dai MH; Xiong J; Zhang S; Wu HJ; Zhang SS; Gong ZJ
    Mol Cancer; 2018 Jan; 17(1):3. PubMed ID: 29310682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased expression of Beclin‑1 is significantly associated with a poor prognosis in oral tongue squamous cell carcinoma.
    Hu Z; Zhong Z; Huang S; Wen H; Chen X; Chu H; Li Q; Sun C
    Mol Med Rep; 2016 Aug; 14(2):1567-73. PubMed ID: 27356955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deregulation of Hexokinase II Is Associated with Glycolysis, Autophagy, and the Epithelial-Mesenchymal Transition in Tongue Squamous Cell Carcinoma under Hypoxia.
    Chen G; Zhang Y; Liang J; Li W; Zhu Y; Zhang M; Wang C; Hou J
    Biomed Res Int; 2018; 2018():8480762. PubMed ID: 29682563
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High expression of TMEM40 contributes to progressive features of tongue squamous cell carcinoma.
    Zhang Q; Huang D; Zhang Z; Feng Y; Fu M; Wei M; Zhou J; Huang Y; Liu S; Shi R
    Oncol Rep; 2019 Jan; 41(1):154-164. PubMed ID: 30320346
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The downregulation of ANGPTL4 inhibits the migration and proliferation of tongue squamous cell carcinoma.
    Huang Z; Xie J; Lin S; Li S; Huang Z; Wang Y; Ye J
    Arch Oral Biol; 2016 Nov; 71():144-149. PubMed ID: 27505034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting non-canonical autophagy overcomes erlotinib resistance in tongue cancer.
    Huang K; Liu D
    Tumour Biol; 2016 Jul; 37(7):9625-33. PubMed ID: 26797786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melatonin Exerts Anticancer Effects in Human Tongue Squamous Cell Carcinoma Cells by Promoting Autophagy.
    Sung ES; Kim JY; Ahn YT; Lee IW; Choi SW; Jang HB; Lee JC; An WG
    Anticancer Res; 2020 Nov; 40(11):6295-6303. PubMed ID: 33109567
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-611 promotes the proliferation, migration and invasion of tongue squamous cell carcinoma cells by targeting FOXN3.
    Chen S; Zhang J; Sun L; Li X; Bai J; Zhang H; Li T
    Oral Dis; 2019 Nov; 25(8):1906-1918. PubMed ID: 31419344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Odd-skipped related transcription factor 1 (OSR1) suppresses tongue squamous cell carcinoma migration and invasion through inhibiting NF-κB pathway.
    Chen W; Wu K; Zhang H; Fu X; Yao F; Yang A
    Eur J Pharmacol; 2018 Nov; 839():33-39. PubMed ID: 30244004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Suppression of N-Glycosylation of Zinc Finger Protein 471 Affects Proliferation, Invasion, and Docetaxel Sensitivity of Tongue Squamous Cell Carcinoma via Regulation of c-Myc.
    Liu Y; Cai X; Hu S; Wang Z; Tian H; Wang H
    Am J Pathol; 2024 Jun; 194(6):1106-1125. PubMed ID: 38749608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA-137 suppresses tongue squamous carcinoma cell proliferation, migration and invasion.
    Sun L; Liang J; Wang Q; Li Z; Du Y; Xu X
    Cell Prolif; 2016 Oct; 49(5):628-35. PubMed ID: 27571935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-24 promotes the proliferation, migration and invasion in human tongue squamous cell carcinoma by targeting FBXW7.
    Zhao J; Hu C; Chi J; Li J; Peng C; Yun X; Li D; Yu Y; Li Y; Gao M; Zheng X
    Oncol Rep; 2016 Aug; 36(2):1143-9. PubMed ID: 27350307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FoxM1 promotes epithelial-mesenchymal transition, invasion, and migration of tongue squamous cell carcinoma cells through a c-Met/AKT-dependent positive feedback loop.
    Yang H; Wen L; Wen M; Liu T; Zhao L; Wu B; Yun Y; Liu W; Wang H; Wang Y; Wen N
    Anticancer Drugs; 2018 Mar; 29(3):216-226. PubMed ID: 29360662
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Xenotropic and polytropic retrovirus receptor 1 (XPR1) promotes progression of tongue squamous cell carcinoma (TSCC) via activation of NF-κB signaling.
    Chen WC; Li QL; Pan Q; Zhang HY; Fu XY; Yao F; Wang JN; Yang AK
    J Exp Clin Cancer Res; 2019 Apr; 38(1):167. PubMed ID: 30995931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.